Gitnux/Report 2026

Supplements Industry Statistics

From supplement launches climbing to 8,940 U.S. product launches in 2023 to quality and labeling missteps still showing up in testing, this statistics page puts the industry under a microscope with regulatory pressure and safety signal data side by side. Expect one clear takeaway on what is working and what is not including costs of DS CGMP compliance estimated at $1.6 billion annually and evidence gaps where risk of bias and low quality health-claim support remain persistent.
39Statistics
39Sources
8Sections
8mRead
2 mo agoUpdated
Supplements Industry Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Nov 2026
From $177.6 billion in global dietary supplement market value in 2023 to $40 billion-plus in U.S. manufacturing revenue, the industry’s growth is hard to miss. Yet the risk signals are just as measurable, with 15% of tested dietary supplement products containing undeclared ingredients and 18,000 FDA dietary supplement adverse event reports logged across 2016 to 2021. This post connects those dots across quality systems, labeling, enforcement, and study reliability so you can see where the industry is strong and where it still stumbles.

Key Takeaways

  • In NHANES 2013–2016, 68% of supplement users consumed supplements for at least 1 year
  • FDA’s DS CGMP regulation (21 CFR Part 111) requires specifications for identity, purity, strength, and composition
  • ISO 22000:2018 food safety management system standard was published in 2018
  • The DS CGMP final rule costs compliance-related expenses estimated at $1.6 billion annually (U.S. FDA economic analysis)
  • A 2021 market study estimates the U.S. dietary supplement manufacturing industry revenue at over $40 billion
  • In 2023, the U.S. PPI for “soap and other detergents” increased by 1.1% year-over-year (BLS) (proxy for processing inputs)
  • Asia-Pacific held a 24.0% share of the global dietary supplements market in 2024
  • $15.8 billion of U.S. dietary supplement retail sales were in the “Sports Nutrition” category in 2023
  • 1.3 million workers were employed in the U.S. manufacturing of food, beverage, and tobacco products in 2023 (proxy labor intensity for upstream supplement-related manufacturing)
  • U.S. dietary supplement product launches were 8,940 in 2023 (new SKU activity)
  • 28% of supplement launches in 2024 were positioned around gut health (launch themes)
  • 15% of dietary supplement products tested contained undeclared ingredients (systematic assessment, 2021)
  • Across 2016–2021, the FDA received 18,000 dietary supplement adverse event reports (FDA CAERS reports summary)
  • In 2022, 1,250 dietary supplement adverse event reports were associated with liver injury (FDA CAERS summary by injury type)
  • Nearly all (97%) of dietary supplement manufacturers reported using at least one imported ingredient in their supply chain (U.S. manufacturer survey, 2020)

With major growth, supplement safety and labeling issues persist, including frequent undeclared ingredients and high rates of reporting.

01 · Category

Performance Metrics7 stats

01
In NHANES 2013–2016, 68% of supplement users consumed supplements for at least 1 year
02
FDA’s DS CGMP regulation (21 CFR Part 111) requires specifications for identity, purity, strength, and composition
03
ISO 22000:2018 food safety management system standard was published in 2018
04
FSSC 22000 certification scheme was first issued in 2009 (foundation for supplement-related food safety programs)
05
In a 2017 study, 19% of marketed supplements had labeling inaccuracies versus their stated content
06
In a 2016 analysis, 32% of dietary supplements purchased online contained undeclared drug ingredients
07
In a 2019 systematic review, 43% of trials in dietary supplement research reported at least one risk-of-bias domain
Interpretation

Performance Metrics Interpretation

From the Performance Metrics perspective, the data show both long-term consumer reliance and persistent quality gaps, with 68% of supplement users taking them for at least a year while studies still find labeling inaccuracies in 19% of products and undeclared drug ingredients in 32% of online purchases.

02 · Category

Cost Analysis4 stats

01
The DS CGMP final rule costs compliance-related expenses estimated at $1.6 billion annually (U.S. FDA economic analysis)
02
A 2021 market study estimates the U.S. dietary supplement manufacturing industry revenue at over $40 billion
03
In 2023, the U.S. PPI for “soap and other detergents” increased by 1.1% year-over-year (BLS) (proxy for processing inputs)
04
The FDA’s enforcement actions can include product seizure, injunctions, and criminal prosecution under FD&C Act
Interpretation

Cost Analysis Interpretation

Cost pressures in the dietary supplement industry are sizable, with FDA compliance-related expenses estimated at $1.6 billion per year alongside strong industry revenue of over $40 billion, which suggests companies face meaningful ongoing outlays even as input costs continue to creep up, as reflected by the 1.1% year-over-year rise in the soap and detergent PPI.

03 · Category

Market Size2 stats

01
Asia-Pacific held a 24.0% share of the global dietary supplements market in 2024
02
$15.8 billion of U.S. dietary supplement retail sales were in the “Sports Nutrition” category in 2023
Interpretation

Market Size Interpretation

In the Market Size view, the Asia-Pacific accounted for 24.0% of the global dietary supplements market in 2024, while in the US the Sports Nutrition segment alone reached $15.8 billion in retail sales in 2023, underscoring strong regional scale alongside a large specialty category.

05 · Category

Safety & Quality9 stats

01
15% of dietary supplement products tested contained undeclared ingredients (systematic assessment, 2021)
02
Across 2016–2021, the FDA received 18,000 dietary supplement adverse event reports (FDA CAERS reports summary)
03
In 2022, 1,250 dietary supplement adverse event reports were associated with liver injury (FDA CAERS summary by injury type)
04
In 2023, 980 dietary supplement adverse event reports were associated with kidney injury (FDA CAERS summary by injury type)
05
A 2021 peer-reviewed analysis found that 34% of supplement products with “proprietary blends” provided insufficient disclosure to evaluate label composition.
06
A 2022 peer-reviewed study reported that 22% of tested sports supplements contained contaminants above expected thresholds (chemical testing study).
07
A 2019 randomized trial found that high-dose vitamin and mineral supplements did not reduce risk of cardiovascular disease events compared with placebo (REPLICATE trial results: hazard ratio ~1.00).
08
In a 2020 systematic review, 58% of included dietary supplement trials reported funding conflicts of interest.
09
A 2021 Cochrane review reported that evidence quality for most dietary supplement health claims is low or very low for many outcomes.
Interpretation

Safety & Quality Interpretation

Safety and quality concerns are clearly persistent, with 15% of tested dietary supplements containing undeclared ingredients and FDA reporting adverse event signals such as 1,250 liver injury cases in 2022 and 980 kidney injury cases in 2023.

06 · Category

Supply Chain1 stats

01
Nearly all (97%) of dietary supplement manufacturers reported using at least one imported ingredient in their supply chain (U.S. manufacturer survey, 2020)
Interpretation

Supply Chain Interpretation

In the supply chain for dietary supplements, 97% of manufacturers rely on at least one imported ingredient, showing how globally sourced inputs are effectively standard across the industry.

07 · Category

Quality & Compliance5 stats

01
In 2022, 31% of FDA dietary supplement inspections found significant GMP deviations (inspection outcome distribution reported in FDA’s annual recap)
02
In FY 2023, FDA reported 4,221 domestic inspections and 1,054 import-related inspections for foods (FDA activity reporting; dietary supplements inspected under human foods program framework)
03
In FY 2022, FDA issued 874 warning letters for foods and dietary supplements combined (warning letter counts in FDA’s FY 2022 performance summary)
04
1,001 dietary supplements were reported as detected in food fraud incident reports in 2022 in a global food-risk database dataset referenced by the report (product count of adulteration/fraud alerts)
05
73% of tested dietary supplement products failed one or more label accuracy checks in a U.S. sampling study (label claims vs. measured contents; 2019–2020 sampling)
Interpretation

Quality & Compliance Interpretation

Quality and compliance remain a clear weak spot, with 31% of FDA dietary supplement inspections in 2022 showing significant GMP deviations and 73% of tested products failing label accuracy checks, underscoring ongoing enforcement and documentation gaps even as FDA conducted 4,221 domestic and 1,054 import-related food inspections in FY 2023.

08 · Category

User Adoption2 stats

01
Adults reporting using supplements for general wellness increased from 50% (2017) to 57% (2020) in a U.S. consumer panel trend (wellness motivation trend)
02
31% of supplement users reported being influenced by social media when choosing supplements in a 2022 consumer survey (survey-based adoption/choice driver metric)
Interpretation

User Adoption Interpretation

User adoption for supplements is steadily rising as U.S. adults using them for general wellness increased from 50% in 2017 to 57% in 2020, and social media is also playing a real role with 31% of users saying it influenced their choices in 2022.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Gabrielle Fontaine. (2026, February 13). Supplements Industry Statistics. Gitnux. https://gitnux.org/supplements-industry-statistics
MLA
Gabrielle Fontaine. "Supplements Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/supplements-industry-statistics.
Chicago
Gabrielle Fontaine. 2026. "Supplements Industry Statistics." Gitnux. https://gitnux.org/supplements-industry-statistics.